Nocturia in Menopausal Women: The Link Between Two Common Problems of the Middle Age.
Genitourinary symptoms
Hormonal treatment
Menopause
Nocturia
Nocturnal polyuria
Sleep disorders
Journal
International urogynecology journal
ISSN: 1433-3023
Titre abrégé: Int Urogynecol J
Pays: England
ID NLM: 101567041
Informations de publication
Date de publication:
04 Mar 2024
04 Mar 2024
Historique:
received:
06
05
2023
accepted:
29
12
2023
medline:
4
3
2024
pubmed:
4
3
2024
entrez:
4
3
2024
Statut:
aheadofprint
Résumé
The aim of this review is to discuss the link between menopause and nocturia and to give an overview of the increasing prevalence, risk factors, causative factors, treatment needs and options for nocturia in peri-menopausal women. This opinion article is a narrative review based on the expertise and consensus of a variety of key opinion leaders, in combination with an extensive literature review. This literature search included a thorough analysis of potential publications on both the PubMed Database and the Web of Science and was conducted between November 2022 and December 2022. The following key words were used "nocturia" and "menopause" or "nocturnal frequency and menopause." Moreover, key words including "incidence," "prevalence," "insomnia," "estrogen therapy," "metabolic syndrome," and "hot flushes" were used in combination with the aforementioned key words. Last, the reference lists of articles obtained were screened for other relevant literature. The perimenopause can be a trigger for inducing nocturia. Typically, obesity, body mass index (BMI), and waist circumference are risk factors for developing peri-menopausal nocturia. Presumably the development of peri-menopausal nocturia is multifactorial, with interplay among bladder, sleep, and kidney problems due to estrogen depletion after the menopause. First, impaired stimulation of estrogen receptors in the urogenital region leads to vaginal atrophy and reduced bladder capacity. Moreover, menopause is associated with an increased incidence of overactive bladder syndrome. Second, estrogen deficiency can induce salt and water diuresis through blunted circadian rhythms for the secretion of antidiuretic hormone and the activation of the renin-angiotensin-aldosterone system. Additionally, an increased incidence of sleep disorders, including vasomotor symptoms and obstructive sleep apnea signs, is observed. Oral dryness and a consequent higher fluid intake are common peri-menopausal symptoms. Higher insulin resistance and a higher risk of cardiovascular diseases may provoke nocturia. Given the impact of nocturia on general health and quality of life, bothersome nocturia should be treated. Initially, behavioral therapy should be advised. If these modifications are inadequate, specific treatment should be proposed. Systemic hormone replacement is found to have a beneficial effect on nocturia, without influencing sodium and water clearance in patients with nocturnal polyuria. It is presumed that the improvement in nocturia from hormonal treatment is due to an improvement in sleep disorders.
Identifiants
pubmed: 38436669
doi: 10.1007/s00192-024-05743-1
pii: 10.1007/s00192-024-05743-1
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The International Urogynecological Association.
Références
Hashim H, Blanker MH, Drake MJ, et al. International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function. Neurourol Urodyn. 2019; 38:499–508.
doi: 10.1002/nau.23917
Andersson F, Anderson P, Holm-Larsen T, Piercy J, Everaert K, Holbrook T. Assessing the impact of nocturia on health-related quality-of-life and utility: results of an observational survey in adults. J Med Econ. 2016;19:1200–6. https://doi.org/10.1080/13696998.2016.1211136 .
doi: 10.1080/13696998.2016.1211136
Tikkinen KAO, Johnson TM, Tammela TLJ, et al. Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland. Eur Urol. 2010;57:488–98..
doi: 10.1016/j.eururo.2009.03.080
Vaughan CP, Fung CH, Huang AJ, Johnson TM, Markland AD. Differences in the association of nocturia and functional outcomes of sleep by age and gender: a cross-sectional, population-based study. Clin Ther. 2016;38:2386–93.e1.
doi: 10.1016/j.clinthera.2016.09.009
Pauwaert K, Bruneel E, van Laecke E, Depypere H, Everaert K, Goessaert AS. Does hormonal therapy affect the bladder or the kidney in postmenopausal women with and without nocturnal polyuria: results of a pilot trial? Maturitas. 2022;160:61–7.
doi: 10.1016/j.maturitas.2022.01.009
Everaert K, Hervé F, Bosch R, et al. International Continence Society consensus on the diagnosis and treatment of nocturia. Neurourol Urodyn. 2019;38:478–98. https://doi.org/10.1002/nau.23939 .
doi: 10.1002/nau.23939
Varella LRD, Bezerra da Silva R, Eugênia de Oliveira MC, et al. Assessment of lower urinary tract symptoms in different stages of menopause. J Phys Ther Sci. 2016;28:3116–21.
doi: 10.1589/jpts.28.3116
Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19:1.
Hsu A, Nakagawa S, Walter LC, et al. The burden of nocturia among middle-aged and older women. Obstet Gynecol. 2015;125:35–43.
doi: 10.1097/AOG.0000000000000600
Rekers H, Drogendijk AC, Valkenburg HA, Riphagen F. The menopause, urinary incontinence and other symptoms of the genito-urinary tract. Maturitas. 1992;15:101–11.
doi: 10.1016/0378-5122(92)90244-X
Srisukho S, Pantasri T, Piyamongkol W, Phongnarisorn C, Morakote N. The experience of genitourinary syndrome of menopause (GSM) among Thai postmenopausal women: the non-reporting issue. Int Urogynecol J. 2019;30:1843–7.
doi: 10.1007/s00192-019-03991-0
Jones HJ, Huang AJ, Subak LL, Brown JS, Lee KA. Bladder symptoms in the early menopausal transition. J Womens Health (Larchmt). 2016;25:457–63.
doi: 10.1089/jwh.2015.5370
Tikkinen KAO, Auvinen A, Tiitinen A, Valpas A, Johnson TM, Tammela TLJ. Reproductive factors associated with nocturia and urinary urgency in women: a population-based study in Finland. Am J Obstet Gynecol. 2008;199:153.e1–12.
doi: 10.1016/j.ajog.2008.03.054
Tikkinen KAO, Johnson TM, Tammela TLJ, et al. Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland. Eur Urol. 2010;57:488–96.
doi: 10.1016/j.eururo.2009.03.080
Asplund R, Åberg HE. Nocturia and health in women aged 40–64 years. Maturitas. 2000;35:143–8.
doi: 10.1016/S0378-5122(00)00111-0
Chen YC, den Chen G, Hu SW, Lin TL, Lin LY. Is the occurrence of storage and voiding dysfunction affected by menopausal transition or associated with the normal aging process? Menopause. 2003;10:203–8.
doi: 10.1097/00042192-200310030-00005
Pauwaert K, Goessaert A-S, Ghijselings L, Bower W, Depypere H, Everaert K. Characterizing nocturia among Belgian healthy postmenopausal women: prevalence, bother, etiology and possible risk factors for developing nocturia. Maturitas. 2020;143:41–6.
doi: 10.1016/j.maturitas.2020.08.008
Terauchi M, Hirose A, Akiyoshi M, Owa Y, Kato K, Kubota T. Prevalence and predictors of storage lower urinary tract symptoms in perimenopausal and postmenopausal women attending a menopause clinic. Menopause. 2015;22:1084–90.
doi: 10.1097/GME.0000000000000432
Nakagawa H, Niu K, Hozawa A, et al. Impact of nocturia on bone fracture and mortality in older individuals: a Japanese longitudinal cohort study. J Urol. 2010;184:1413–8.
doi: 10.1016/j.juro.2010.05.093
Tang R, Fan Y, Luo M, et al. General and central obesity are associated with increased severity of the VMS and sexual symptoms of menopause among Chinese women: a longitudinal study. Front Endocrinol (Lausanne). 2022;13:814872.
doi: 10.3389/fendo.2022.814872
Hetemäki N, Savolainen-Peltonen H, Tikkanen MJ, et al. Estrogen metabolism in abdominal subcutaneous and visceral adipose tissue in postmenopausal women. J Clin Endocrinol Metab. 2017;102:4588–95.
doi: 10.1210/jc.2017-01474
Lizcano F. Roles of estrogens, estrogen-like compounds, and endocrine disruptors in adipocytes. Front Endocrinol (Lausanne). 2022;13:921504.
doi: 10.3389/fendo.2022.921504
Pauwaert K, Goessaert A-S, Ghijselings L, et al. Hormone therapy as a possible solution for postmenopausal women with nocturia. Menopause. 2021;28:502–10.
doi: 10.1097/GME.0000000000001741
Everaert K, Hervé F, Bower W, Djurhuus JC, Dmochowski R, Fine N, et al. How can we develop a more clinically useful and robust algorithm for diagnosing and treating nocturia? ICI-RS 2017. Neurourol Urodyn. 2018;37:S46–59.
Bower WF, Rose GE, Whishaw DM, Ervin CF, Wang AC, Moore KH. The association between nocturia, hormonal symptoms and bladder parameters in women: an observational study. BJOG. 2022;129:812–9.
doi: 10.1111/1471-0528.16752
Leimola-Virtanen R, Salo T, Toikkanen S, Pulkkinen J, Syrjänen S. Expression of estrogen receptor (ER) in oral mucosa and salivary glands. Maturitas. 2000;36:131–7.
doi: 10.1016/S0378-5122(00)00138-9
Minicucci EM, Pires RBC, Vieira RA, Miot HA, Sposto MR. Assessing the impact of menopause on salivary flow and xerostomia. Aust Dent J. 2013;58:230–4.
doi: 10.1111/adj.12057
Asplund R, Åberg HE. Oral dryness, nocturia and the menopause. Maturitas. 2005;50:86–90.
doi: 10.1016/j.maturitas.2004.04.009
Chagnac A. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol. 2003;14:1480–6. https://doi.org/10.1097/01.ASN.0000068462.38661.89 .
doi: 10.1097/01.ASN.0000068462.38661.89
Cardozo L, Robinson D, Dmochowski RR, et al. Special considerations in premenopausal and postmenopausal women with symptoms of overactive bladder. Urology. 2002;60:64–71; discussion 71.
doi: 10.1016/S0090-4295(02)01799-5
Blümel JE, Chedraui P, Baron G, et al. Menopausal symptoms appear before the menopause and persist 5 years beyond: a detailed analysis of a multinational study. Climacteric. 2012;15:542–51.
doi: 10.3109/13697137.2012.658462
Portman DJ, Gass MLS, Kingsberg S, et al. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Menopause. 2014;21:1063–8.
doi: 10.1097/GME.0000000000000329
Robinson D, Toozs-Hobson P, Cardozo L. The effect of hormones on the lower urinary tract. Menopause Int. 2013;19:155–62.
doi: 10.1177/1754045313511398
Pfisterer MH-D, Griffiths DJ, Rosenberg L, Schaefer W, Resnick NM. Parameters of bladder function in pre-, peri-, and postmenopausal continent women without detrusor overactivity. Neurourol Urodyn. 2007;26:356–61.
doi: 10.1002/nau.20381
Parsons M, Amundsen CL, Cardozo L, Vella M, Webster GD, Coats AC. Bladder diary patterns in detrusor overactivity and urodynamic stress incontinence. Neurourol Urodyn. 2007;26:800–6. https://doi.org/10.1002/nau.20406 .
doi: 10.1002/nau.20406
Hristov KL, Parajuli SP, Provence A, Rovner ES, Petkov GV. Nongenomic modulation of the large conductance voltage- and Ca
doi: 10.14814/phy2.13351
Potier M, Karl M, Zheng F, Elliot SJ, Striker GE, Striker LJ. Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens. Am J Pathol. 2002;160:1877–85.
doi: 10.1016/S0002-9440(10)61134-0
Potier M, Elliot SJ, Tack I, et al. Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J Am Soc Nephrol. 2001;12:241–51.
doi: 10.1681/ASN.V122241
Oelkers WHK. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy. Climacteric. 2005;8:19–27. https://doi.org/10.1080/13697130500330341 .
doi: 10.1080/13697130500330341
Forsling ML, Akerlund M, Stromberg P. Variations in plasma concentrations of vasopressin during the menstrual cycle. J Endocrinol. 1981;89:263–6.
doi: 10.1677/joe.0.0890263
Goessaert A-S, vande Walle J, Kapila A, Everaert K. Hormones and nocturia: guidelines for medical treatment? J Steroids Horm Sci. 2014. https://doi.org/10.4172/2157-7536.1000130 .
doi: 10.4172/2157-7536.1000130
Tani M, Hirayama A, Fujimoto K, Torimoto K, Akiyama T, Hirao Y. Increase in 24-hour urine production/weight causes nocturnal polyuria due to impaired function of antidiuretic hormone in elderly men. Int J Urol. 2008;15:151–4.
doi: 10.1111/j.1442-2042.2007.01949.x
Graugaard-Jensen C, Hvistendahl GM, Frøkiær J, Bie P, Djurhuus JC. The influence of high and low levels of estrogen on diurnal urine regulation in young women. BMC Urol. 2008;8:16.
doi: 10.1186/1471-2490-8-16
Stachenfeld NS, DiPietro L, Palter SF, Nadel ER. Estrogen influences osmotic secretion of AVP and body water balance in postmenopausal women. Am J Physiol Regul Integr Comp Physiol. 1998;274:R187–95.
doi: 10.1152/ajpregu.1998.274.1.R187
Oelkers WKH. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids. 1996;61:166–71.
doi: 10.1016/0039-128X(96)00007-4
Kolatorova L, Vitku J, Suchopar J, Hill M, Parizek A. Progesterone: a steroid with wide range of effects in physiology as well as human medicine. Int J Mol Sci. 2022;23:7989.
doi: 10.3390/ijms23147989
Komukai K, Mochizuki S, Yoshimura M. Gender and the renin-angiotensin-aldosterone system. Fundam Clin Pharmacol. 2010;24:687–98.
doi: 10.1111/j.1472-8206.2010.00854.x
Bossmar T, Forsling M, Åkerlund M. Circulating oxytocin and vasopressin is influenced by ovarian steroid replacement in women. Acta Obstet Gynecol Scand. 1995;74:544–8.
doi: 10.3109/00016349509024387
Jeong HG, Park H. Metabolic disorders in menopause. Metabolites. 2022;12:954.
doi: 10.3390/metabo12100954
Tom SE, Kuh D, Guralnik JM, Mishra GD. Self-reported sleep difficulty during the menopausal transition: results from a prospective cohort study. Menopause. 2010;17:1128–35.
doi: 10.1097/gme.0b013e3181dd55b0
Kravitz HM, Zhao X, Bromberger JT, et al. Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women. Sleep. 2008;31:979.
Dennerstein L, Lehert P, Guthrie JR, Burger HG. Modeling women’s health during the menopausal transition: a longitudinal analysis. Menopause. 2007;14:53–62.
doi: 10.1097/01.gme.0000229574.67376.ba
Freedman RR. Hot flashes: behavioral treatments, mechanisms, and relation to sleep. Am J Med. 2005;118:124–30.
doi: 10.1016/j.amjmed.2005.09.046
Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, Meyer PM. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause. 2003;10:19–28.
Kapsimalis F, Kryger M. Sleep breathing disorders in the U.S. female population. J Womens Health (Larchmt). 2009;18:1211–9.
doi: 10.1089/jwh.2008.1054
Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med. 2001;163:608–13. https://doi.org/10.1164/ajrccm.163.3.9911064 .
doi: 10.1164/ajrccm.163.3.9911064
Shepertycky MR, Banno K, Kryger MH. Differences between men and women in the clinical presentation of patients diagnosed with obstructive sleep apnea syndrome. Sleep. 2005;28:309–14.
Dancey DR, Hanly PJ, Soong C, Lee B, Hoffstein V. Impact of menopause on the prevalence and severity of sleep apnea. Chest. 2001;120:151–5.
doi: 10.1378/chest.120.1.151
Young T, Finn L, Austin D, Peterson A. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med. 2003;167:1181–5. https://doi.org/10.1164/rccm.200209-1055OC .
doi: 10.1164/rccm.200209-1055OC
Umlauf MG, Chasens ER, Greevy RA, Arnold J, Burgio KL, Pillion DJ. Obstructive sleep apnea, nocturia and polyuria in older adults. Sleep. 2004;27:139–44.
doi: 10.1093/sleep/27.1.139
Hirayama A, Torimoto K, Yamada A, Tanaka N, Fujimoto K, Yoshida K, et al. Relationship between nocturnal urine volume, leg edema, and urinary antidiuretic hormone in older men. Urology. 2011;77:1426–31.
Torimoto K, Hirayama A, Samma S, Yoshida K, Fujimoto K, Hirao Y. The relationship between nocturnal polyuria and the distribution of body fluid: assessment by bioelectric impedance analysis. J Urol. 2009;181:219–24.
doi: 10.1016/j.juro.2008.09.031
Wali MA, Raparelli V, Pilote L, Daskalopoulou SS. Blood pressure variability in normotensive perimenopausal women: non-dipping status, maximum blood pressure and arterial stiffness. Int J Cardiol. 2021;325:149–54.
doi: 10.1016/j.ijcard.2020.10.027
McKeigue PM, Reynard JM. Relation of nocturnal polyuria of the elderly to essential hypertension. Lancet. 2000;355:486–8. https://doi.org/10.1016/S0140-6736(00)82039-5 .
doi: 10.1016/S0140-6736(00)82039-5
Carpenter J, Gass MLS, Maki PM, et al. Nonhormonal management of menopause-associated vasomotor symptoms. Menopause. 2015;22:1155–74.
doi: 10.1097/GME.0000000000000546
Harding CK, Lapitan MC, Bø K, et al. EAU Guidelines on the management of non-neurogenic female lower urinary tract symptoms (LUTS). EAU Guidelines. Presented at the EAU Annual Congress Milan 2021; 2020.
Weiss JP. Nocturia: focus on etiology and consequences. Rev Urol. 2012;14:48–55.
Hanna-Mitchell AT, Robinson D, Cardozo L, Everaert K, Petkov GV. Do we need to know more about the effects of hormones on lower urinary tract dysfunction? ICI-RS 2014. Neurourol Urodyn. 2016;35:299–303.
doi: 10.1002/nau.22809
Weiss JP, Everaert K. Management of nocturia and nocturnal polyuria. Urology. 2019;133:24–33. https://doi.org/10.1016/j.urology.2019.09.022 .
doi: 10.1016/j.urology.2019.09.022
Oelke M, de Wachter S, Drake MJ, Giannantoni A, Kirby M, Orme S, et al. A practical approach to the management of nocturia. Int J Clin Pract. 2017;71(11):e13027. https://doi.org/10.1111/ijcp.13027 .
Miyauchi Y, Okazoe H, Okujyo M, et al. Effect of the continuous positive airway pressure on the nocturnal urine volume or night-time frequency in patients with obstructive sleep apnea syndrome. Urology. 2015;85:333–6.
doi: 10.1016/j.urology.2014.11.002
Ghijselings L, Hervé F, Van der Aa F, et al. Development of a flowchart reflecting the current attitude and approach towards idiopathic overactive bladder treatment in Belgium: a Delphi study. Neurourol Urodyn. 2020;39:1781–95 https://doi.org/10.1002/nau.24421 .
doi: 10.1002/nau.24421
Margel D, Shochat T, Getzler O, Livne PM, Pillar G. Continuous positive airway pressure reduces nocturia in patients with obstructive sleep apnea. Urology. 2006;67:974–7.
doi: 10.1016/j.urology.2005.11.054
Viaene A, Roggeman S, Goessaert AS, et al. Conservative treatment for leg oedema and the effect on nocturnal polyuria in patients with spinal cord injury. BJU Int. 2019;123:E43–50.
doi: 10.1111/bju.14672
Juul KV, Bichet DG, Nielsen S, Nørgaard JP. The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors. Am J Physiol Renal Physiol. 2014;306:F931–40.
doi: 10.1152/ajprenal.00604.2013
Long CY, Liu CM, Hsu SC, Chen YH, Wu CH, Tsai EM. A randomized comparative study of the effects of oral and topical estrogen therapy on the lower urinary tract of hysterectomized postmenopausal women. Fertil Steril. 2006;85:155–60.
doi: 10.1016/j.fertnstert.2005.06.042
Santen RJ. Vaginal administration of estradiol: effects of dose, preparation and timing on plasma estradiol levels. Climacteric. 2015;18:121–34. https://doi.org/10.3109/13697137.2014.947254 .
doi: 10.3109/13697137.2014.947254
The 2017 hormone therapy position statement of the North American Menopause Society. Menopause. 2018;25:1362–87.
Cardozo L, Lose G, McClish D, Versi E. A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder. Acta Obstet Gynecol Scand. 2004;83:892–7.
doi: 10.1111/j.0001-6349.2004.00581.x
Reynard JM, Cannon A, Yang Q, Abrams P. A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo. Br J Urol. 1998;81:215–8. https://doi.org/10.1046/j.1464-410X.1998.00511.x .
doi: 10.1046/j.1464-410X.1998.00511.x
Miyazato M, Tohyama K, Touyama M, et al. Effect of continuous positive airway pressure on nocturnal urine production in patients with obstructive sleep apnea syndrome. Neurourol Urodyn. 2017;36:376–9. https://doi.org/10.1002/nau.22936 .
doi: 10.1002/nau.22936
Rahn DD, Carberry C, Sanses TV, et al. Vaginal estrogen for genitourinary syndrome of menopause. Obstet Gynecol. 2014;124:1147–56.
doi: 10.1097/AOG.0000000000000526
Cistulli PA, Barnes DJ, Grunstein RR, et al. Effect of short term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax. 1994;49:699–702.
doi: 10.1136/thx.49.7.699
Bower WF, Rose GE, Ervin CF, Goldin J, Whishaw DM, Khan F. TANGO—a screening tool to identify comorbidities on the causal pathway of nocturia. BJU Int. 2017;119:933–41.
doi: 10.1111/bju.13774
Rose GE, Bower WF. Development of a scoring process for the nocturia causality screening tool TANGO: a rationale and methodology. Aust N Z Continence J. 2020;26:3.
Decalf V, Everaert K, de Witte N, Petrovic M, Bower W. Dutch version of the TANGO nocturia screening tool: cross-culturally translation and reliability study in community-dwelling people and nursing home residents. Acta Clin Belg. 2020;75(6):397–404.
doi: 10.1080/17843286.2019.1653511
Pauwaert K, Goessaert AS, Ghijselings L, Monaghan TF, Depypere H, Everaert K. Nocturia through the menopausal transition and beyond: a narrative review. Int Urogynecol J. 2021;32:1097–106.
doi: 10.1007/s00192-020-04640-7
Kok ALM, Burger CW, van de Weijer PHM, Voetberg GA, Peters-Muller ERA, Kenemans P. Micturition complaints in postmenopausal women treated with continuously combined hormone replacement therapy: a prospective study. Maturitas. 1999;31:143–9.
doi: 10.1016/S0378-5122(98)00093-0
Leimola-Virtanen R, Helenius H, Laine M. Hormone replacement therapy and some salivary antimicrobial factors in post- and perimenopausal women. Maturitas. 1997;27:145–51.
doi: 10.1016/S0378-5122(97)00024-8
MacLennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev. 2004;2004:CD002978.
Shahar E, Redline S, Young T, Boland LL, Baldwin CM, Nieto FJ, et al. Hormone replacement therapy and sleep-disordered breathing. Am J Respir Crit Care Med. 2003;167:1186–92.